Default



Default

Home | Contact Us | Site Index | Search UW:

Edward D. Verrier, M.D.

 Ed Verrier photo

Patient Services:

Surgery Specialty Center at UWMC, Thursdays 1:00-5:00 pm
Phone: 206-598-4300
Patient Scheduling: 206-598-8200 or toll-free:
1-866-UW HEART (894-3278)
Administrative Assistant: Ambika Beck, 206-685-8644

Academic Office:

Phone: 206-685-3370

E-mail:
edver@u.washington.edu

Fax: 206-616-9063

Address:
Edward D. Verrier, M.D.
University of Washington
Division of Cardiothoracic Surgery
Box 356310
Seattle, WA 98195-6310

Professor
Vice Chairman, Clinical Affairs
Chief, Division of Cardiothoracic Surgery

Faculty Appointments:

University of Washington, Professor and Chief, Cardiothoracic Surgery, 1989 - present.

William K. Edmark Professor of Cardiovascular Surgery, 1993 - present.

University of California, San Francisco, Associate Professor, 1989.

Education:

Schering Scholarship: American College of Surgeons, 1981.

Residency: University of California, San Francisco, 1974-76.

M.D. Degree: Tufts University, 1974.

Board Certified: American Board of General Surgery, 1984; Recertified, 1993, 2003. American Board of Thoracic Surgery, 1985; Recertified, 1993, 2003.

Clinical Interests:

Adult cardiac surgery: myocardial revascularization, valvular repair and replacement, thoracic aortic surgery, congenital heart disease (adult), transplantation.

Research Interests:

Vascular biology: endothelial cell function, neutrophil function, cardiopulmonary bypass physiology, ischemia/reperfusion, myocardial protection, systemic inflammation.

download Annual Research Report

Selected Publications:

Gold JP, Begg WB, Fullerton DA, Mathisen DJ, Orringer MB. Verrier ED: Evaluation of web-based learning tools: lessons learned from the thoracic surgery directors association curriculum project three-year experience. Ann Thorac Surg. 80(3):802-9; discussion 809-10, 2005.

Carrier M, Ménasché P, Levy JH, Newman MF, Taylor KM, Haverich A, Chen JC, Shernan SK, Van de Werf F, van der Laan M, Todaro TG, Adams PX, Verrier ED: Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery. J Thorac Cardiovasc Surg. 131(2):352-6, 2006.

 

reviewed 06/06